Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of nodal upstaging in clinical N1 nonsmall cell lung cancer.
Kayawake H, Okami J, Shintani Y, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Endo S, Kadokura M, Nakanishi R, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Kayawake H, et al. Among authors: yoshino i. Jpn J Clin Oncol. 2024 Nov 13:hyae161. doi: 10.1093/jjco/hyae161. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39537201
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
Hayashi H, Nishio M, Akamatsu H, Goto Y, Miura S, Gemma A, Yoshino I, Misumi T, Kijima T, Takase N, Fujita M, Tasaka S, Mouri A, Kondo T, Takamura K, Kawashima Y, Imaizumi K, Iwasawa S, Nakagawa S, Mitsudomi T. Hayashi H, et al. Among authors: yoshino i. Cancer Res Commun. 2024 Nov 1;4(11):2858-2867. doi: 10.1158/2767-9764.CRC-24-0212. Cancer Res Commun. 2024. PMID: 39392339 Free PMC article.
Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL.
Yagishita S, Goto Y, Nishio M, Akamatsu H, Hayashi H, Miura S, Tamada K, Kagamu H, Hamada A, Ohuchi M, Gemma A, Yoshino I, Misumi T, Hata A, Hara S, Kijima T, Masaki F, Iwasawa S, Nakagawa S, Tatsuno M, Mitsudomi T. Yagishita S, et al. Among authors: yoshino i. JTO Clin Res Rep. 2024 May 16;5(7):100683. doi: 10.1016/j.jtocrr.2024.100683. eCollection 2024 Jul. JTO Clin Res Rep. 2024. PMID: 39091595 Free PMC article.
Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data.
Hishida T, Okami J, Asamura H, Miyaoka E, Shintani Y, Kadokura M, Endo S, Chida M, Suzuki H, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Hishida T, et al. Among authors: yoshino i. Clin Lung Cancer. 2024 Sep;25(6):519-528.e3. doi: 10.1016/j.cllc.2024.05.010. Epub 2024 May 27. Clin Lung Cancer. 2024. PMID: 38906754 Free article.
Updated outcomes of surgical treatment for recurrent thymic tumour: a report from the Japanese nationwide database.
Mizuno T, Chen-Yoshikawa TF, Yoshino I, Okumura M, Ikeda N, Kuroda K, Maniwa Y, Kanzaki M, Suzuki M; Japanese Association for Research on the Thymus. Mizuno T, et al. Among authors: yoshino i. Interdiscip Cardiovasc Thorac Surg. 2024 Jun 5;38(6):ivae064. doi: 10.1093/icvts/ivae064. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38897650 Free PMC article.
513 results